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Abstract
Background: Nasal strips are used by athletes, people who snore, and asthmatics to ease the
burden of breathing. Although there are some published studies that demonstrate higher flow with
nasal strips, none had directly measured the effect of the strips on nasal resistance using the airflow
perturbation device (APD). The APD is an inexpensive instrument that can measure respiratory
resistance based on changes in mouth pressure and rate of airflow.
Method: This study tested forty-seven volunteers (14 men and 33 women), ranging in age from
17 to 51. Each volunteer was instructed to breathe normally into the APD using an oronasal mask
with and without nasal strips. The APD measured respiratory resistance during inhalation,
exhalation, and an average of the two.
Results:  Results of a paired mean t-test comparing nasal strip against no nasal strip were
statistically significant at the p = 0.05 level. The Breathe Right™ nasal dilator strips lowered nasal
resistance by an average of 0.5 cm H20/Lps from an average nasal resistance of 5.5 cm H20/Lps.
Conclusions: Nasal strips reduce nasal resistance when measured with the APD. The effect is
equal during exhalation and during inhalation.
Background
Nasal dilator strips (NDS) are used by athletes, people
who snore, and asthmatics to ease the burden of breath-
ing. The nasal strips are used as a mechanical means of
reducing nasal airflow resistance [1]. By lowering nasal
resistance, they reduce the work of breathing and the sup-
ply of oxygen into the body could increase [2,3].
The size of the nostril limits the amount of air entering
into the body. The NDS is placed along the nasal valve of
the nose. The adhesiveness of the strip binds to the creases
of the nasal valve to prevent the outer wall tissue of the
nose from collapsing inward during nasal breathing. This
mechanism thus dilates the nose and allows more air to
flow into the nose [3].
The primary effect of the NDS could be either to dilate the
air passage of the nose or to stiffen the nasal wall. Either
mechanism would reduce nasal resistance and allow
higher flow of air, but they can be distinguished over a
range of air flows. Stiffening the nasal wall would have its
most profound effect at higher flows where the Bernoulli
effect would decrease internal nasal pressures and tend to
constrict nasal passage diameter. Air passage dilation
Published: 22 October 2004
BioMedical Engineering OnLine 2004, 3:38 doi:10.1186/1475-925X-3-38
Received: 16 March 2004
Accepted: 22 October 2004
This article is available from: http://www.biomedical-engineering-online.com/content/3/1/38
© 2004 Wong and Johnson; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BioMedical Engineering OnLine 2004, 3:38 http://www.biomedical-engineering-online.com/content/3/1/38
Page 2 of 7
(page number not for citation purposes)
would tend to decrease nasal resistance more uniformly
over a range of air flows.
Recent studies on the effectiveness of Breathe Right™ nasal
strips tested participants under various rest and exercise
conditions. Some found that the strips neither improve or
diminish airflow [2,4-9], which contradict results found
by others [1,3,10-14]. Various techniques were used to
assess NDS effectiveness. Some measured the amount of
airflow, others the area of the nostrils, and still others the
nasal airflow resistance.
The Airflow Perturbation Device (APD) is a small, light
weight, and easy to use instrument that measures respira-
tory resistance [15]. A segmented rotating wheel in the air
flow path changes air flow and mouth pressure as the
wheel momentarily partially obstructs the flow passage
(Figure 1). The magnitude of these perturbations depends
on the resistance of the wheel and respiratory resistance.
Measurement of wheel resistance allows respiratory resist-
ance to be calculated directly (Figure 2). Resistance values
appear on a computer screen within a minute from start-
ing the measurement. Thereafter they are updated as they
occur.
People breathe normally through the APD. No special
breathing maneuvers are required. For this reason, the
APD can be used with young children, older adults,
unconscious patients, and animals. Respiratory resistance
can be separated into inhalation and exhalation compo-
nents, and resistance can be displayed against lung vol-
ume and air flow rate.
Respiratory resistance is normally measured through the
mouth, with a nose clip and hands pressed against the
cheeks. An oronasal mask may be used to obtain com-
bined mouth and nose resistance, or nose resistance by
itself if the mouth is closed. The APD used with an orona-
sal mask should be an ideal instrument to assess the effect
of NDS.
This study is as much a test of the capabilities of the APD
as it is a study of NDS. Objectives of this study were to: 1)
determine if APD measurements of respiratory resistance
measured with an oronasal mask matched those with
breathing through a mouthpiece, and 2) measure the
effects of NDS on respiratory resistance made with the
APD. This is not a clinical study.
Methods
This study tested forty-seven volunteers (14 men, 33
women; age 17–51 yr; height 147–188 cm; weight 38–
105 kg). Some had symptoms of nasal congestion such as
asthma, allergies, and snoring. A written informed con-
sent was obtained from each subject and the protocol was
approved by the University of Maryland Institutional
Review Board (IRB).
The nasal strips used in this study were a commercial
product called "Breathe Right" (CNS, Inc., Minneapolis,
MN, clear, medium/large nasal strips). According to the
manufacturer's instructions, the nasal strips should be
placed halfway down the nose along the nasal valve. The
The APD Sensor consists of a rotating wheel in the air path,  a pneumotach, and pressure transducers [15] Figure 1
The APD Sensor consists of a rotating wheel in the air path, 
a pneumotach, and pressure transducers [15]
The APD system consists of pressure and flow transducers,  analog-to-digital conversion, and a computer display of  results [1] Figure 2
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two end regions of the nasal strips should cover the left
and right nasal creases.
This study contained three phases: 1) to determine the
ability of the APD to measure oral resistance using either
a mouthpiece or an oronasal mask, 2) to determine the
ability of the APD to measure nasal resistance, and 3) to
determine the effect of nasal strips on nasal resistances.
Phase I consisted of two tests that measured oral breathing
resistance. In the first test, the subject's nose was occluded
with two layers of Durapore surgical tape (3 M, St. Paul,
MN) while the subjects were sitting in an upright position.
The subject was instructed to breathe normally into a
cardboard mouthpiece. The second test repeated the same
procedure as the first test, except the subject was breathing
into an oronasal mask (Adult Mask 4–5+, Laerdal Medical,
Wappingers Falls, NY). The subject was instructed to press
their face against the mask while he/she breathed nor-
mally. The size of the mask was large enough that it con-
tacted only the hard tissue on the bridge of the nose and
did not compress the soft nasal septum.
The second phase of this study consisted of a test to meas-
ure nasal breathing resistance. The subject was instructed
to breathe normally through the nose with the mouth
closed and with no NDS. For the third phase, the subject
placed a NDS across the nasal valve on his/her nose as
shown on the instructions provided by the manufacturer.
In both of these tests, the oronasal mask was used.
Air flow perturbations with the APD occur at a rate of
about 10 per second [15]. Measurements were obtained in
these experiments over approximately 100 perturbations.
It has been previously found that measurements made
over that time are relatively stable and reproducible [15].
Several time-averaged resistance values are displayed:
resistance during inhalation, 2) resistance during exhala-
tion, and 3) the average of inhalation and exhalation
resistances. All three of these have been found to be
useful.
Primary comparisons for this study were made using the
average respiratory resistance. Secondary comparisons in
the second phase of this study investigated the effects of
NDS on inhalation and exhalation respiratory resistances.
Statistical comparisons were made using a paired mean t-
test with significance at the p = 0.05 level.
Results
Subject data appear in Table 1. Average resistance meas-
ured during mouth breathing with mouthpiece ranges
from 1.90 to 5.03 cm H2O/Lps. In the past, average
respiratory resistances for healthy adults have generally
fallen in the range of 2.5 - 3.5 cm H2O/Lps, and such is the
case here. Also, as expected, most respiratory resistance
values during exhalation exceed those measured during
inhalation.
Breathing through the mouth into the oronasal mask
yielded almost the same values. Means of values with the
mouthpieces and oronasal mask are 3.24 and 3.21,
respectively. The difference was not statistically significant
using a paired-t test at p = 0.05.
Figure 3 shows the graph of average respiratory resistance
of mask vs. mouthpiece while breathing through the
mouth. The graph has a slope of nearly 1.0 and an inter-
cept of nearly 0.0, indicating a nearly perfect correspond-
ence between the two methods of measurement. Both
slope and intercept were tested statistically and the line
was found to be identical to y = x at the p = 0.05 level.
Comparison of inhalation resistance between mouthpiece
and oronasal mask yielded the following equation:
y = 0.9624 + 0.1041 R2 = 0.8435  (1)
where y = mask value of resistance and x = mouthpiece
value of resistance
This equation was tested to be statistically equivalent to y
= x. This indicates that the oronasal mask had no effect on
the inhalation values.
A similar comparison of exhalation resistances gave the
following:
y = 0.874bx + 0.4594 R2 = 0.8828  (2)
This equation did not pass the statistical test for equiva-
lence y = x. The oronasal mask may have affected the
measurement of respiratory resistance in the exhalation
direction.
Figure 4 shows the relationship of average respiratory
resistance when breathing through the nose measured
with and without the nasal strips. The NDS data have a
slope of nearly 1.0 and a y-intercept is approximately -0.4.
This signifies a reduction of nasal breathing resistance
using the nasal strip. Nasal resistances with no nasal strip
range from 3.53 to 7.73 cm H2O/Lps, while nasal resist-
ance with the NDS ranges from 3.39 to 7.33 cm H2O/Lps.
This demonstrates the expected resistance reduction with
NDS.
All subjects except three showed a decrease in nasal resist-
ance when breathing with the NDS. Average value of nose
breathing without NDS was 5.50; with NDS it was 5.00.
These means were highly statistically significantly
different.BioMedical Engineering OnLine 2004, 3:38 http://www.biomedical-engineering-online.com/content/3/1/38
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The effect of NDS on resistance during exhalation was also
statistically highly significant. There was an average reduc-
tion of 0.45 cm H2O/Lps in resistance, and only six out of
47 subjects failed to demonstrate a decrease in resistance
with NDS.
The effect of NDS on resistance during inhalation tested to
be statistically highly significant, as well. The average
resistance reduction was 0.49 cm H20/dps. Again, six sub-
jects failed to demonstrate a decrease in resistance with
NDS. These were not the same subjects that increased
resistance in the exhalation direction.
Resistance differences with and without NDS in the inha-
lation and exhalation directions were tested to determine
if NDS had a larger effect while breathing in one direction
or the other. Means of the differences for inhalation and
exhalation directions were tested with a paired t-test, and
found to be statistically nonsignificant. It appears, there-
fore, that NDS affect nasal resistances equally during inha-
lation and exhalation.
Discussion
This study confirmed the results of other studies that
showed a reduction of about 10% in nasal breathing
resistance, as well as supported the claim of the manufac-
turer that the nasal strips provide nasal relief. Several sub-
jects who had nasal congestion reported some relief in
nasal breathing when using the nasal strip. Exactly which
subjects these were was not recorded.
There was one surprise, though, in the results. The reduc-
tion in respiratory resistance due to NDS was a constant
amount and not proportional to the resistance level
present without NDS. This result was not expected, and no
adequate explanation for it can be given at this time. It is
not clear why this should be so, but we do not doubt that
measurements made with the APD are correct, based on
previous studies [15,16].
Average oral respiratory resistance measured with a mouthpiece and an oronasal mask Figure 3
Average oral respiratory resistance measured with a mouthpiece and an oronasal mask. There is almost perfect agreement 
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We cannot comment on the clinical significance of the
resistance reduction with NDS use. It seems likely that
some benefit could be obtained from such a resistance
change, but whether it is actually detectable is not clear.
Other reports in the literature [17,18] have concluded that
the minimum detectable external resistance is about a
constant 25–30% proportion of the resistance already
present. The resistance change measured in this study is
Table 1: Subject data for APD Measurements of Respiratory Resistance when Measured Through the Mouth and Nose. Resistances are 
given in cm H2O/Lps.
Subject No. Sex Mouth Piece Mask Mouth Mask Nose Mask NDS
Inh Avg Exh Inh Avg Exh Inh Avg Exh Inh Avg Exh
1 F 3.15 3.06 2.97 2.86 3.08 3.30 4.65 5.13 5.61 4.08 4.13 4.18
2 F 3.00 3.26 3.52 2.98 3.29 3.59 5.84 5.72 5.59 3.64 3.47 3.30
3 F 2.69 3.19 3.68 2.84 3.38 3.92 4.94 5.73 6.52 4.55 5.26 5.97
4 F 4.00 4.62 5.25 3.97 4.46 4.95 5.40 5.87 6.31 5.11 5.45 5.79
5 F 3.13 4.04 4.95 3.58 4.11 4.63 5.33 5.59 5.85 4.62 5.30 5.98
6 M 2.14 2.41 2.69 2.10 2.34 2.58 3.76 4.15 4.53 3.71 4.16 4.61
7 F 2.73 3.15 3.85 2.43 3.11 3.79 3.92 4.16 4.39 3.54 3.62 3.69
8 M 2.03 2.33 2.64 2.12 2.24 2.36 4.32 4.50 4.69 3.65 3.85 4.06
9 M 1.87 1.96 2.06 1.83 1.82 1.80 3.16 3.53 3.91 3.26 3.47 3.68
10 M 3.49 3.95 4.41 3.27 3.90 4.52 5.96 6.27 6.57 6.13 6.20 6.28
11 F 2.89 2.97 3.04 2.76 2.91 3.07 7.59 7.33 7.07 7.48 7.05 6.61
12 F 3.67 4.24 4.82 4.18 4.38 4.58 6.36 7.14 7.92 6.75 6.82 6.90
13 M 2.20 2.54 2.89 2.13 2.49 2.84 5.27 5.50 5.73 4.80 5.04 5.27
14 F 3.08 2.98 2.88 2.98 3.07 3.17 5.12 5.25 5.38 5.34 5.36 5.38
15 M 2.37 2.45 2.53 2.64 2.77 2.90 5.44 5.63 5.82 5.33 5.57 5.81
16 M 3.48 3.58 3.68 3.16 3.47 3.77 5.71 5.30 4.90 4.71 4.88 5.04
17 M 2.40 2.85 3.30 2.22 2.74 3.26 4.54 4.90 5.25 4.38 4.70 5.07
18 F 2.96 2.96 2.95 2.95 3.04 3.12 6.84 7.19 7.54 6.71 6.89 7.07
19 M 2.00 2.30 2.59 2.54 2.10 1.67 3.82 4.25 4.68 3.20 3.39 3.57
20 F 2.40 2.85 3.30 2.81 2.77 2.73 4.12 4.16 4.20 3.61 3.73 3.85
21 F 4.22 4.20 4.17 4.34 4.42 4.49 6.76 6.97 7.10 6.36 6.75 7.14
22 F 2.73 3.12 3.50 3.02 3.12 3.22 6.60 6.74 6.89 5.90 6.08 6.26
23 F 4.87 5.03 5.19 4.49 4.96 5.42 5.96 6.23 6.70 5.06 5.30 5.54
24 F 4.38 4.79 5.20 4.41 4.64 4.87 6.35 6.68 7.01 5.70 6.05 6.39
25 F 2.61 3.02 3.44 2.51 2.94 3.36 3.98 4.03 4.08 3.56 3.42 3.28
26 M 2.12 2.42 2.71 1.80 2.26 2.71 5.87 5.84 5.81 5.31 4.38 5.44
27 F 3.22 3.77 4.31 3.48 3.58 3.68 4.51 4.76 5.01 4.24 4.58 4.93
28 F 2.85 3.01 3.17 2.74 2.94 3.14 4.71 4.64 4.56 3.57 4.17 4.76
29 F 2.84 3.26 3.67 3.04 3.39 3.75 4.94 5.56 6.18 4.40 5.04 5.68
30 F 2.76 3.08 3.40 2.81 3.05 3.29 6.24 6.40 6.56 5.57 5.76 5.94
31 F 2.90 3.21 3.51 2.68 2.88 3.09 4.71 4.88 5.04 5.03 5.16 5.29
32 M 1.76 1.90 2.03 1.54 1.87 2.20 4.02 4.49 4.97 4.00 4.18 4.35
33 F 3.65 3.94 4.23 3.76 3.92 4.09 4.90 5.30 5.71 4.90 5.26 5.61
34 M 1.94 2.15 2.36 1.97 2.17 2.36 5.19 4.90 4.61 4.37 4.36 4.36
35 F 2.78 2.93 3.09 2.81 3.05 3.29 3.81 4.45 5.10 3.75 4.20 4.65
36 F 5.21 5.09 4.97 4.46 4.81 5.71 4.81 5.19 5.56 4.00 4.04 4.08
37 F 3.18 3.44 3.69 3.02 3.34 3.66 5.49 5.70 5.91 5.50 5.58 5.65
38 F 2.77 3.48 4.20 2.62 3.31 4.00 6.70 6.60 6.51 5.97 6.12 6.26
39 F 3.66 3.57 3.48 3.53 3.54 3.55 7.62 7.73 7.83 6.94 7.33 7.72
40 F 2.57 3.05 3.52 2.58 2.97 3.36 3.64 4.13 4.63 3.58 3.78 3.98
41 F 3.76 3.74 3.71 3.17 3.68 4.18 4.70 5.11 5.51 4.13 4.54 4.95
42 M 3.27 3.39 3.58 3.43 3.61 3.80 6.08 6.44 6.79 5.90 6.25 6.60
43 F 3.27 3.65 4.03 3.89 3.68 4.47 4.47 4.78 5.09 3.69 3.98 4.27
44 M 2.23 2.51 2.79 2.17 2.34 2.51 6.48 6.42 6.35 5.87 6.01 6.15
45 F 2.09 2.95 3.02 2.98 3.07 3.16 6.10 6.65 7.20 5.86 6.20 6.55
46 F 2.98 3.12 3.26 3.15 3.23 3.30 5.70 5.65 5.60 4.57 4.68 4.78
47 F 2.67 2.64 2.61 2.56 2.56 2.57 4.35 4.74 5.12 3.29 3.64 3.99
Average 2.96 3.24 3.51 2.96 3.21 3.48 5.24 5.50 5.74 4.80 5.00 5.25
Std dev 0.76 0.75 0.82 0.73 0.76 0.88 1.09 1.02 1.03 1.11 1.10 1.12BioMedical Engineering OnLine 2004, 3:38 http://www.biomedical-engineering-online.com/content/3/1/38
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about 10% of the baseline resistance. If the use of NDS
does result in a detectable change, then it may be that a
different detection mechanism is operating. It is possible
that the subject could detect nasal resistance only, rather
than total respiratory resistance. Based on that supposi-
tion, NDS reduce nasal resistance by about 17%.
The APD has been shown to be able to measure respira-
tory resistance with either a mouthpiece or an oronasal
mask. This may be a significant advantage of the instru-
ment, especially because respiratory resistance measure-
ment on unconscious or uncooperative patients would be
much more easily made with a mask than with a mouth-
piece. Equations (1) and (2) show the close correspond-
ence between measurements made with both techniques,
although the presence of an intercept and a slope different
from unity indicate that the correspondence between
mask and mouthpiece is not perfect. Resistances with a
mask are both higher than resistances with a mouthpiece.
The reason for this seems to be different mouth positions
in both cases. We have laboratory experiences (not pub-
lished) that demonstrate that tongue position can influ-
ence measured resistance. Breathing through the mask is
probably done with the mouth closed more than when
breathing through the mouthpiece. The measured
difference between inhalation and exhalation resistances
could reflect the effect of a pressure difference across the
distensible smaller airways, which is greater inside than
outside during inhalation, but smaller inside than outside
during exhalation. This would lead to a dynamic compres-
sion of the small intrathoracic airways during exhalation.
Another possible explanation is natural movement of the
vocal chords such that they are closer during exhalation
than during inhalation.
This study was a good test of the capabilities of the APD
measuring device. Testing confirmed that the APD can
detect resistance changes, and that measurements are easy
to obtain. Results in this study are generally more consist-
ent than other studies using other techniques [1-11]. The
fact that the APD directly measures respiratory resistance,
and is not an indirect measurement may be one reason for
this consistency. Then, again, our subject population
exhibited some homogeneity in age, social class, and
racial makeup.
Conclusions
Nasal strips reduce nasal resistance by about 0.5 cm H2O/
Lps. Thus, nasal strips do have a measurable effect on
nasal resistance. The effect of NDS appears to be equal
during exhalation and during inhalation.
Average respiratory resistance while breathing through the nose in 47 subjects Figure 4
Average respiratory resistance while breathing through the nose in 47 subjects. Nasal strips showed a decrease of nasal resist-
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The APD can be used to measure nasal resistance, and can
detect resistance levels.
The APD can consistently measure oral resistance with
either a mask or a mouthpiece.
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